AnaSpec Introduces Fifty-Five New Catalog Peptides

PRLog (Press Release) – Aug 29, 2007 – August 29, 2007 – San Jose, CA

Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced fifty-five (55) new peptides for drug discovery research.

Beta-Amyloid (1-11)-Lys (Biotin) - Cat# 62135
Beta-Amyloid (1-17)-Lys(Biotin-LC) - Cat# 62136
[Gly10;11]-beta-Amyloid (1-11) - Cat# 62138
Beta-Amyloid (16-24) - Cat# 62139
[Gly11;12] -beta-Amyloid (1-13)-Lys(Biotin) - Cat# 62134
TAT-NSF222scr Fusion Polypeptide; scrambled - Cat# 62210
GLP-2 (1-34); Glucagon-ike Peptide-2 (1-34); human - Cat# 62068
C34-LC-Biotin; gp41 HIV fragment - Cat# 62103
3;4 Dehydro-Pro-Arg-Vasotocin - Cat# 62097
MBP p68–86; Myelin Basic Protein p68–86 - Cat# 62081
?-C2/V1 (49-53); ? PKC; C2 Domain (49-53) - Cat# 62175
?-C2/V1; ? PKC; C2 Domain (119-124) - Cat# 62177
CLP24 (187-201); Claudin-like Protein 24 (187-201); human - Cat# 62172
Gamma-Fibrinogen (377-395) - Cat# 62128
Gamma-Fibrinogen (377-395); scrambled - Cat# 62129
Glu-Glu epitope Tag - Cat# 62189
Pro-apoptotic Peptide; klaklakklaklak; 5/6-FAM-labeled - Cat# 62206
Beta-Amyloid (1-17) - Cat# 61955
Beta-Amyloid (1-9) - Cat# 61970
Beta-Amyloid (25-35); Scrambled - Cat# 61971
Beta-Amyloid (22-42) - Cat# 61972
Beta-Amyloid (1-9)-Lys(Biotin-LC)-NH2 - Cat# 61973
Beta-Amyloid (8-40) - Cat# 61975
Beta-Amyloid (30–34) - Cat# 61977
Beta-Amyloid (17–24) - Cat# 61978
[Cys3]-beta-Amyloid (4-10) - Cat# 61979
Beta-Amyloid (35-42) - Cat# 61981
Beta-Amyloid (33-40) - Cat# 61982
Amyloid Precursor Protein (APP) (44-62) - Cat# 61983
[Phe34]-beta-Amyloid (25-35) - Cat# 61984
Beta-Amyloid (26-40) - Cat# 61985
Beta-Amyloid (20-42) - Cat# 61989
[Met-1;Leu35]-beta-Amyloid (1-42) - Cat# 61957-01
Beta-Amyloid (17-24); biotinylated - Cat# 61980
Nociceptin (1-13); amide - Cat# 61950-5
M2 (127-135); Respiratory Syncytial Virus (RSV)-specific peptide (127-135) - Cat# 62021
NPSF (1-37); Neuropeptide SF (1-37) - Cat# 62016
NPVF - Cat# 62006
TIF2 (740-753); Transcriptional Intermediary Factor 2 (740-753) - Cat# 61992
RIP (817-828); Receptor Interacting Protein (817-828) - Cat# 61996
SRC 1 (1433-1441); Steroid Receptor Co-activator 1 (1433-1441) - Cat# 61999
TIF2 (682-700) box 2; Transcriptional Intermediary Factor 2 (682-700); Box2 - Cat# 62000
TIF2 (636-649); Transcriptional Intermediary Factor 2 (636-649); Box1 - Cat# 61993
RIP (131-142); Receptor Interacting Protein (131-142). - Cat# 61995
RIP (498-509); Receptor Interacting Protein (498-509) - Cat# 61997
SRC 1 (1433-1440); Steroid Receptor Co-activator (1433-1440) - Cat# 61998
105Y; alpha1-antitrypsin (359-374) - Cat# 62004
EGFR (662-681) - Cat# 62013
Hemoglobin; 3037a; Malaria FRET Substrate II - Cat# 62014
Hemoglobin; 2837a; Malaria FRET substrate III - Cat# 62015
PKC zeta 560 - Cat# 62020
Microtubule-associated Protein 7; MAP7; mouse (CT) - Cat# 61952
Microtubule-associated Protein 7 (MAP7); mouse (NT) - Cat# 61953
Aquaporin 2 (241-271); AQP2 (241-271) - Cat# 62007
MKK4 Docking Site peptide - Cat# 62001

Company Info
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry.  Established in 1993, AnaSpec's headquarters and manufacturing facilities are located in San Jose, CA.